EMILI; ANDREW
Patent Applications and Registrations
Patent applications and USPTO patent grants for EMILI; ANDREW.The latest application filed is for "protein sequencing methods and reagents".
- EMILI; ANDREW - NEEDHAM MA
- Emili; Andrew - Toronto CA
- Emili; Andrew - Milton CA
- Emili, Andrew - Ontario CA
| Patent | Date |
|---|---|
| Protein Sequencing Methods And Reagents App 20220155316 - EMILI; ANDREW | 2022-05-19 |
| Protein sequencing methods and reagents Grant 11,268,963 - Emili March 8, 2 | 2022-03-08 |
| Use of IGFBP-7 in the assessment of heart failure Grant 10,996,229 - Wienhues-Thelen , et al. May 4, 2 | 2021-05-04 |
| Protein Sequencing Method And Reagents App 20200141944 - Emili; Andrew ; et al. | 2020-05-07 |
| Use Of Igfbp-7 In The Assessment Of Heart Failure App 20200064359 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2020-02-27 |
| Use of IGFBP-7 in the assessment of heart failure Grant 10,488,422 - Wienhues-Thelen , et al. Nov | 2019-11-26 |
| Protein sequencing method and reagents Grant 10,481,162 - Emili , et al. Nov | 2019-11-19 |
| Protein Sequencing Method And Reagents App 20180372752 - Emili; Andrew ; et al. | 2018-12-27 |
| Protein Sequencing Methods And Reagents App 20180299460 - EMILI; ANDREW | 2018-10-18 |
| Protein Sequencing Method And Reagents App 20170212126 - Emili; Andrew ; et al. | 2017-07-27 |
| Protein sequencing method and reagents Grant 9,566,335 - Emili , et al. February 14, 2 | 2017-02-14 |
| Use Of Igfbp-7 In The Assessment Of Heart Failure App 20170016918 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2017-01-19 |
| Use Of Alpha-crystallin B (cryab) In The Assessment Of Heart Failure App 20160146836 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2016-05-26 |
| Use of SLIM-1 in the assessment of heart failure Grant 9,267,954 - Wienhues-Thelen , et al. February 23, 2 | 2016-02-23 |
| Use Of Igfbp-7 In The Assessment Of Heart Failure App 20150293122 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2015-10-15 |
| Use Of Sfrp-3 In The Assessment Of Heart Failure App 20140193845 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2014-07-10 |
| Use of SFRP-3 in the assessment of heart failure Grant 8,691,587 - Wienhues-Thelen , et al. April 8, 2 | 2014-04-08 |
| Method for the identification of macromolecule targets of analytes Grant 8,192,999 - Emili June 5, 2 | 2012-06-05 |
| Use Of Biglycan In The Assessment Of Heart Failure App 20110165591 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2011-07-07 |
| Use Of Sfrp-3 In The Assessment Of Heart Failure App 20110027819 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2011-02-03 |
| Use Of Slim-1 In The Assessment Of Heart Failure App 20100285492 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2010-11-11 |
| Use Of Igfbp-7 In The Assessment Of Heart Failure App 20100285491 - Wienhues-Thelen; Ursula-Henrike ; et al. | 2010-11-11 |
| Protein Expression Profile Database App 20100137151 - Emili; Andrew ; et al. | 2010-06-03 |
| Method for the Identification of Macromolecule Targets of Analytes App 20080311610 - Emili; Andrew | 2008-12-18 |
| Automatic sample loader for use with a mass spectrometer Grant 7,109,477 - Kuzan , et al. September 19, 2 | 2006-09-19 |
| Automatic sample loader for use with a mass spectrometer App 20050218318 - Kuzan, Pawel ; et al. | 2005-10-06 |
| Protein expression profile database App 20050048564 - Emili, Andrew ; et al. | 2005-03-03 |
| NCAGE Code | L5875 | EMILI, ANDREW |
| CAGE Code | L5875 | EMILI, ANDREW |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 